Insider Transactions in Q4 2020 at Teladoc Health, Inc. (TDOC)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2020
|
Yulun Wang Head of Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+50.0%
|
$72,000
$16.92 P/Share
|
|
Dec 14
2020
|
Yulun Wang Head of Research & Development |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$497,500
$199.24 P/Share
|
|
Dec 14
2020
|
Yulun Wang Head of Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$40,000
$16.92 P/Share
|
|
Dec 10
2020
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-26.29%
|
$576,000
$192.17 P/Share
|
|
Dec 10
2020
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+20.81%
|
$66,000
$22.3 P/Share
|
|
Dec 08
2020
|
Hemant Taneja Director |
SELL
Open market or private sale
|
Indirect |
4,900
-100.0%
|
$965,300
$197.39 P/Share
|
|
Dec 04
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-13.09%
|
$408,000
$204.0 P/Share
|
|
Dec 04
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+11.58%
|
$44,000
$22.3 P/Share
|
|
Dec 04
2020
|
Yulun Wang Head of Research & Development |
SELL
Open market or private sale
|
Direct |
6,069
-100.0%
|
$1,213,800
$200.0 P/Share
|
|
Dec 04
2020
|
Yulun Wang Head of Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
6,069
+50.0%
|
$97,104
$16.92 P/Share
|
|
Dec 03
2020
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-0.82%
|
$1,000,000
$200.52 P/Share
|
|
Dec 03
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
1,389
-25.7%
|
$277,800
$200.0 P/Share
|
|
Dec 03
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,389
+20.45%
|
$30,558
$22.3 P/Share
|
|
Dec 03
2020
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
2,611
-92.89%
|
$511,756
$196.5 P/Share
|
|
Dec 03
2020
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
2,611
+38.03%
|
$78,330
$30.4 P/Share
|
|
Dec 01
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-23.15%
|
$792,000
$198.66 P/Share
|
|
Dec 01
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+18.8%
|
$88,000
$22.3 P/Share
|
|
Dec 01
2020
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
25,000
-3.92%
|
$4,850,000
$194.27 P/Share
|
|
Nov 27
2020
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
3,924
-3.75%
|
$761,256
$194.89 P/Share
|
|
Nov 25
2020
|
Sandra L Fenwick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,173
+16.8%
|
-
|
|
Nov 25
2020
|
Karen L Daniel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,173
+25.37%
|
-
|
|
Nov 25
2020
|
Christopher Bischoff |
BUY
Exercise of conversion of derivative security
|
Direct |
713
+16.18%
|
-
|
|
Nov 10
2020
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-26.29%
|
$540,000
$180.17 P/Share
|
|
Nov 10
2020
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+20.81%
|
$66,000
$22.3 P/Share
|
|
Nov 04
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
1,389
-25.7%
|
$277,800
$200.0 P/Share
|
|
Nov 04
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,389
+20.45%
|
$30,558
$22.3 P/Share
|
|
Nov 04
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-13.09%
|
$408,000
$204.0 P/Share
|
|
Nov 04
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+11.58%
|
$44,000
$22.3 P/Share
|
|
Nov 04
2020
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-0.78%
|
$1,000,000
$200.27 P/Share
|
|
Nov 03
2020
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
25,000
-3.74%
|
$4,825,000
$193.76 P/Share
|
|
Nov 03
2020
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
310
+0.05%
|
$1,860
$6.01 P/Share
|
|
Nov 03
2020
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
2,612
-92.89%
|
$501,504
$192.0 P/Share
|
|
Nov 03
2020
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
2,612
+38.03%
|
$78,360
$30.42 P/Share
|
|
Nov 03
2020
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
78,707
+42.9%
|
-
|
|
Nov 02
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-23.15%
|
$776,000
$194.0 P/Share
|
|
Nov 02
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+18.8%
|
$88,000
$22.3 P/Share
|
|
Oct 30
2020
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
25,911
+50.0%
|
-
|
|
Oct 06
2020
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
30,000
-4.3%
|
$6,660,000
$222.26 P/Share
|
|
Oct 06
2020
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.12%
|
$180,000
$6.01 P/Share
|
|
Oct 05
2020
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
2,610
-92.88%
|
$579,420
$222.46 P/Share
|
|
Oct 05
2020
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
2,610
+38.03%
|
$78,300
$30.42 P/Share
|
|
Oct 05
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
1,389
-25.7%
|
$308,358
$222.46 P/Share
|
|
Oct 05
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,389
+20.45%
|
$30,558
$22.3 P/Share
|
|
Oct 02
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
717
-15.15%
|
$161,325
$225.0 P/Share
|
|
Oct 02
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
717
+13.16%
|
$27,246
$38.55 P/Share
|
|
Oct 01
2020
|
Lewis Levy Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,670
-23.35%
|
$592,740
$222.86 P/Share
|
|
Oct 01
2020
|
Lewis Levy Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,670
+11.05%
|
$98,790
$37.0 P/Share
|
|
Oct 01
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
6,000
-31.13%
|
$1,332,000
$222.86 P/Share
|
|
Oct 01
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+23.74%
|
$132,000
$22.3 P/Share
|